bilaterals.org logo
bilaterals.org logo

GMOs

Genetically modified organisms


Policy space for Mexican maize: Protecting agro-biodiversity by promoting rural livelihoods
With maize trade scheduled to be fully liberalized under NAFTA in 2008, many farm groups are calling for a renegotiation of the treaty’s agricultural provisions to prevent further damage. This analysis examines the room for alternative policies in Mexico under existing economic and environmental agreements, including NAFTA. It concludes that the Mexican government retains access to many useful policy instruments that could promote rural livelihoods while arresting the losses of important maize diversity. What is lacking is the political will to make use of them.
Gender review of the Economic Partnership Agreements
Paper presented to the European Commission in Brussels by Liepollo Lebohang Pheko from IGTN-Africa on the gender impacts of liberalization of Economic Partnership Agreements (EPA).
Mexico shuts the door on GM maize
Mexico has moved to ban experimental fields of genetically modified (GM) maize. But the gateway into Mexico of transgenic maize, in the form of unlabeled grain imports, remains ajar. In 2008, as part of NAFTA, the quotas and other barriers for the entry of US-grown GM maize and beans into Mexico will be eliminated.
Bilateral biosafety bullies
This new briefing from GRAIN and the African Centre for Biosafety looks at how governments, the agribusiness sector and transnational companies are increasingly using bilateral trade agreements to prise open markets for genetically modified crops.
FTA means deeper poverty in Peru
An issue that has received less attention is the implications of the FTA for the entry of genetically modified organisms (GMO’s) into Peru.
WTO is dead, long live free trade: globalisation and its new avatars
Bilateral and unilateral, initiatives are the new avatars of globalisation and free trade. And it is these avatars we must challenge to stop corporate rule, while WTO hangs between intensive care and the crematorium.
NAFTA agreement on trade in GMOs (2004)
Agreement between the US, Canada, and Mexico with respect to the documentation requirements of the Cartagena Protocol on Biosafety pertaining to living modified organisms intended for direct use as food or feed or for processing (LMO/FFPs), signed in October 2004.
Agreement scarce, dispute persists in SK-US free trade talks
South Korea and the US have agreed to establish a standing committee on sanitary standards for agricultural and food products, which will make it easier for the US to ask for expanded trade of genetically modified crops. However, negotiations on pharmaceuticals have hit a snag, with neither side willing to budge.
BIO letter to USTR on US-Korea FTA
Letter from the US Biotechnology Industry Organisation to the US Trade Representative on intellectual property, GM labelling, biosafety, GM contamination and other issues BIO wants addressed under the US-Korea FTA talks.
BIO letter to USTR on US-Malaysia FTA
Letter from the US Biotechnology Industry Organisation to the US Trade Representative on intellectual property, GM labelling, biosafety, GM contamination and other issues BIO wants addressed under the US-Malaysia FTA talks.
Bilateral free trade and investment agreements and the US corporate biotech agenda
Bilateral free trade agreements are seen by the agricultural biotechnology industry as an important conduit for spreading genetically modified organisms (GMOs) around the world.
The US-Peru Trade Promotion Agreement (TPA): The intellectual property provisions
Report of the US government’s Industry Trade Advisory Committee on Intellectual Property Rights (ITAC-15)
Biosafety protocol alive, but restricted
The Cartagena Protocol on Biosafety "is alive," although there were complaints about and criticism of modifications to the final agreement reached at the Third Meeting of the Parties to the Protocol (MOP3). The aim of the compromise that Mexico successfully pressed for is to not hinder the country’s free trade agreements with other countries.
BIO president Jim Greenwood welcomes US FTA negotiations with Malaysia
The Biotechnology Industry Organization (BIO) today applauded the Bush Administration’s announcement to begin free trade negotiations with Malaysia. "Malaysia is an important market with a strong interest in developing its biotechnology industry," stated Jim Greenwood, President and CEO of BIO. "We look forward to working with US Trade Representative Rob Portman on this important initiative as Malaysia looks to enhance the development of its biotechnology sector.
Senate confirms Richard Crowder as USTR Chief Agricultural Negotiator
Crowder has been president and CEO of the American Seed Trade Association since 2002. Prior to that, he was Senior Vice President, International, of DEKALB Genetics Corporation — now part of Monsanto — a worldwide leader in agricultural genetics and seed biotechnology.
As the TNCs catch you: An analysis of the liberalization of biotechnological products in the Thai-US FTA
One of the books the Thai Prime Minister suggested his cabinet members read was “As the Future Catches You” by Juan Enriquez, a Mexican writer. The book’s contents relate to the fact that countries need to catch up with the development of biotechnology. Otherwise they will be alienated and left behind.
Free trade agreement: impact in Thailand
This booklet by FTA Watch is aimed at disseminating information to international civil society for the purpose of sharing the analyses and experience of the FTA struggle in Thailand.
Bilateral agreements imposing TRIPS-plus intellectual property rights on biodiversity in developing countries
A detailed roster of FTAs and other bilateral agreements that impose "TRIPS-plus" standards with regard to biological diversity in developing countries.
US Middle East economic policy: Are trade-based initiatives an effective tool in the war on terrorism?
An assessment published by a US military research outfit.
IT, biotech, pharmaceuticals, agro food are items for enhanced India-EU cooperation
The Associated Chambers of Commerce and Industry of India sees tremendous scope for enhancing economic ties with Europe and has mooted a four pronged strategy for expanding India’s trade basket with the enlarged EU in areas such as information technology & communication, biotech & pharmaceuticals, agro foods processing and textiles.